{"id":"W2024099288","doi":"10.1371/journal.pone.0062183","title":"Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models","year":2013,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Warfarin; Atrial fibrillation; Stroke (engine); Randomized controlled trial; Cost effectiveness; Quality-adjusted life year; Internal medicine; Risk analysis (engineering)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01972017,0.002376656,0.01040082,0.01047927,0.0003714178,0.002846593,0.002468374,0.001812266,0.004169395],"category_scores_gemma":[0.07947411,0.001552037,0.01573852,0.008705584,0.0005730136,0.002334774,0.001131527,0.001587663,0.0002738537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005021702,"about_ca_system_score_gemma":0.009097241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008890986,"about_ca_topic_score_gemma":0.01857528,"domain_scores_codex":[0.9831232,0.01020933,0.003859553,0.0006962789,0.001902228,0.0002093722],"domain_scores_gemma":[0.9205483,0.06796696,0.007559451,0.0009111185,0.002726872,0.0002872652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0009349813,0.00008148754,0.002243948,0.811564,0.1025673,0.0001635703,0.0001187166,0.00708919,0.0001391406,0.00174679,0.002639797,0.07071112],"study_design_scores_gemma":[0.001981224,0.000892709,0.005776989,0.6042386,0.3538386,0.0005497715,0.0001903818,0.007098401,0.000250701,0.004847541,0.02020937,0.0001256354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001836414,0.9950882,0.001101651,0.0005537611,0.00008965239,0.0002358083,0.0007232446,0.00002303423,0.0003483335],"genre_scores_gemma":[0.05367878,0.9404812,0.003947498,0.0004859788,0.0001243857,0.0006761861,0.0004928003,0.00001729119,0.00009592151],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01972017,"threshold_uncertainty_score":0.1042914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3983354097169318,"score_gpt":0.4225470890814149,"score_spread":0.0242116793644831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}